Purchases and Sales Made in Q2 2024 in Pyxis Oncology, Inc. (PYXS)
This table provides information about the institutional ownership of Pyxis Oncology, Inc. (PYXS) during Q2 2024. The information is specifically focused on institutions that hold shares of Pyxis Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-1.5K- 9.62% |
$4.59K - $8.37K
|
14.1K
$16.1K
|
|
|
Aug 14, 2024
Q2 2024
|
Superstring Capital Management LP
New York, NY |
SELL
|
- |
-9.32K- 1.89% |
$28.5K - $52K
|
484K
$552K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-10.6K- 37.42% |
$32.4K - $59K
|
17.7K
$20.2K
|
|
|
Jul 31, 2024
Q2 2024
|
Commonwealth Equity Services, LLC
|
SELL
|
- |
-14K- 46.28% |
$42.8K - $78.1K
|
16.3K
$18.5K
|
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-19.9K- 19.52% |
$60.8K - $111K
|
81.9K
$93.4K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-25.4K- 30.83% |
$77.8K - $142K
|
57K
$65K
|
|
|
Aug 14, 2024
Q2 2024
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-26.6K- 65.68% |
$81.3K - $148K
|
13.9K
$15.8K
|
|
|
Aug 12, 2024
Q2 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-29.6K- 44.9% |
$90.5K - $165K
|
36.3K
$41.4K
|
|
|
Aug 14, 2024
Q2 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-31.4K- 1.21% |
$96K - $175K
|
2.56M
$2.92M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-33.7K- 75.47% |
$103K - $188K
|
11K
$12.5K
|
|
|
Aug 12, 2024
Q2 2024
|
Marathon Trading Investment Management LLC
Radnor, PA |
SELL
|
- |
-40.6K- 71.26% |
$124K - $227K
|
16.4K
$18.7K
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-51.1K- 34.5% |
$156K - $285K
|
96.9K
$111K
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-85K- 55.55% |
$260K - $474K
|
68K
$77.5K
|
|
|
Aug 14, 2024
Q2 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-94.2K- 64.02% |
$288K - $526K
|
53K
$60.4K
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-124K- 92.51% |
$378K - $690K
|
10K
$11.4K
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-140K- 79.91% |
$429K - $781K
|
35.2K
$40.1K
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-160K- 65.97% |
$490K - $893K
|
82.6K
$94.2K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-219K- 65.18% |
$671K - $1.22M
|
117K
$134K
|
|
|
Aug 13, 2024
Q2 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
- |
-592K- 32.97% |
$1.81M - $3.3M
|
1.2M
$1.37M
|